clinical trials in patients with rheumatoid arthritis , osteoarthritis , ankylosing spondylitis , gout and non-articular rheumatism suggest that tenoxicam 20mg daily is an equally effective anti-inflammatory and analgesic agent compared with piroxicam 20mg daily , and that it is at least as well tolerated .
C0003873
rheumatoid arthritis
C0031990
piroxicam